Laccase-mimicking enzymes with synergistic amplification effects on catalytic activity for ergothioneine multi-pattern logic analysis.
Summary
A laccase-mimicking catalyst (CuPH@KMO) enabled dual colorimetric/fluorescent detection of ergothioneine by inhibiting dopamine/resorcinol oxidation to azamonardine, and realized AND/INHIBIT logic-gated analysis. The method was successfully applied to cosmetics and dietary supplements, suggesting a versatile platform for quality control and smart bioanalysis.
Key Findings
- CuPH@KMO showed enhanced catalytic efficiency and broader pH tolerance compared with typical laccase activity.
- Dopamine and resorcinol were oxidized to blue fluorescent azamonardine (Ex=478 nm, Abs=420 nm), enabling dual readouts.
- EGT inhibited the CuPH@KMO-catalyzed reactions, forming the basis for colorimetric and fluorescence detection.
- An AND/INHIBIT logic gate architecture was constructed and the method was successfully applied to cosmetics and dietary supplements.
Clinical Implications
No immediate change to bedside care; however, this platform can improve quality control of cosmetic products and supplements containing ergothioneine, supporting safety, label accuracy, and regulatory compliance.
Why It Matters
Introduces a novel, logic-enabled biosensing modality directly applied to cosmetic product analysis, with high potential to influence analytical quality control. The combination of enzyme mimics, multimodal signals, and logic gates is methodologically innovative.
Limitations
- Analytical performance metrics (e.g., limits of detection, interference panels) are not detailed in the abstract
- Clinical relevance is indirect and broader validation across diverse cosmetic formulations is needed
Future Directions
Quantify detection limits, robustness to interferents, and standardize protocols for regulatory QC; explore on-chip integration and extension to other antioxidant analytes.
Study Information
- Study Type
- Case series
- Research Domain
- Diagnosis
- Evidence Level
- V - Laboratory method development with application to product samples; no clinical outcomes.
- Study Design
- OTHER